| scholarly article | Q13442814 |
| P2093 | author name string | Betsy J Barnes | |
| Erica M Pimenta | |||
| P2860 | cites work | Transgenic overexpression of the CC chemokine CCL21 disrupts T-cell migration | Q43819612 |
| Biomarker discovery in non-small cell lung cancer: integrating gene expression profiling, meta-analysis, and tissue microarray validation. | Q44093400 | ||
| Prognostic significance of signal transducer and activator of transcription 1 activation in breast cancer | Q44175745 | ||
| Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+ T cells | Q44200118 | ||
| Occurrence of tertiary lymphoid tissue is associated with T-cell infiltration and predicts better prognosis in early-stage colorectal cancers | Q45118047 | ||
| The prognostic relevance of tumour-infiltrating plasma cells and immunoglobulin kappa C indicates an important role of the humoral immune response in non-small cell lung cancer | Q45792488 | ||
| Deletion of Irf5 protects hematopoietic stem cells from DNA damage-induced apoptosis and suppresses γ-irradiation-induced thymic lymphomagenesis | Q45799743 | ||
| Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis. | Q46655434 | ||
| Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets | Q48649134 | ||
| Gene expression profiling-based identification of molecular subtypes in stage IV melanomas with different clinical outcome | Q48661799 | ||
| Multiple NF-kappaB and IFN regulatory factor family transcription factors regulate CCL19 gene expression in human monocyte-derived dendritic cells | Q50074840 | ||
| CD20+ tumor-infiltrating lymphocytes have an atypical CD27- memory phenotype and together with CD8+ T cells promote favorable prognosis in ovarian cancer. | Q50955882 | ||
| Characterization of chemokines and adhesion molecules associated with T cell presence in tertiary lymphoid structures in human lung cancer. | Q50993488 | ||
| Human solid tumors contain high endothelial venules: association with T- and B-lymphocyte infiltration and favorable prognosis in breast cancer. | Q50996147 | ||
| CXCR5 expressing human central memory CD4 T cells and their relevance for humoral immune responses. | Q51013752 | ||
| Novel CCL21-vault nanocapsule intratumoral delivery inhibits lung cancer growth | Q21560837 | ||
| Involvement of chemokine receptors in breast cancer metastasis | Q24290909 | ||
| RANK is essential for osteoclast and lymph node development | Q24598872 | ||
| CXCR5⁺ T helper cells mediate protective immunity against tuberculosis | Q24628780 | ||
| B cell attracting chemokine 1 (CXCL13) and its receptor CXCR5 are expressed in normal and aberrant gut associated lymphoid tissue | Q24669900 | ||
| Overexpression of CCL-21/secondary lymphoid tissue chemokine in human dendritic cells augments chemotactic activities for lymphocytes and antigen presenting cells | Q24793668 | ||
| Signal transducer and activator of transcription 3 (STAT3) activation in prostate cancer: Direct STAT3 inhibition induces apoptosis in prostate cancer lines | Q24799458 | ||
| Characteristics of tertiary lymphoid structures in primary cancers | Q27012852 | ||
| Type, density, and location of immune cells within human colorectal tumors predict clinical outcome | Q28131662 | ||
| Two discrete promoters regulate the alternatively spliced human interferon regulatory factor-5 isoforms. Multiple isoforms with distinct cell type-specific expression, localization, regulation, and function | Q28243036 | ||
| Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value | Q28488319 | ||
| STATs in cancer inflammation and immunity: a leading role for STAT3 | Q29547203 | ||
| Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm | Q29614349 | ||
| NF-kappaB at the crossroads of life and death | Q29619302 | ||
| Coordination of intratumoral immune reaction and human colorectal cancer recurrence. | Q51788145 | ||
| CCL19 (ELC) improves TH1-polarized immune responses and protective immunity in a murine Her2/neu DNA vaccination model. | Q52890329 | ||
| Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer. | Q52907227 | ||
| Decreased expression of the chemokine CCL21 in human colorectal adenocarcinomas. | Q53314937 | ||
| CCL21-induced immune cell infiltration. | Q54399582 | ||
| Blocking MAPK signaling downregulates CCL21 in lymphatic endothelial cells and impairs contact hypersensitivity responses. | Q54588886 | ||
| Characteristics and Clinical Impacts of the Immune Environments in Colorectal and Renal Cell Carcinoma Lung Metastases: Influence of Tumor Origin | Q56965716 | ||
| Long-Term Survival for Patients With Non–Small-Cell Lung Cancer With Intratumoral Lymphoid Structures | Q56965922 | ||
| Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape | Q57272360 | ||
| Increased levels of the homeostatic chemokine CXCL13 in human atherosclerosis – Potential role in plaque stabilization | Q57315827 | ||
| Naive B-cell trafficking is shaped by local chemokine availability and LFA-1-independent stromal interactions | Q57897223 | ||
| An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes | Q59067290 | ||
| Expression of the B cell-attracting chemokine CXCL13 in the target organ and autoantibody production in ectopic lymphoid tissue in the chronic inflammatory disease Sjögren's syndrome | Q60548220 | ||
| RANKL Induces Organized Lymph Node Growth by Stromal Cell Proliferation | Q61051808 | ||
| Activation of the lymphotoxin beta receptor by cross-linking induces chemokine production and growth arrest in A375 melanoma cells | Q73064382 | ||
| Antigen-driven clonal proliferation, somatic hypermutation, and selection of B lymphocytes infiltrating human ductal breast carcinomas | Q73537019 | ||
| Targeting of lymphotoxin-alpha to the tumor elicits an efficient immune response associated with induction of peripheral lymphoid-like tissue | Q73588426 | ||
| Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7 | Q77758397 | ||
| CCL21 induces extensive intratumoral immune cell infiltration and specific anti-tumor cellular immunity | Q79712657 | ||
| CXCL13 and CCL21 are expressed in ectopic lymphoid follicles in cutaneous lymphoproliferative disorders | Q80316283 | ||
| Characterization of the CCL21-mediated melanoma-specific immune responses and in situ melanoma eradication | Q80491604 | ||
| The humoral immune system has a key prognostic impact in node-negative breast cancer | Q81561686 | ||
| An immune response enriched 72-gene prognostic profile for early-stage non-small-cell lung cancer | Q83133034 | ||
| The Association of Intratumoral Germinal Centers with early-stage non-small cell lung cancer | Q84278335 | ||
| Prognostic impact of B-cell density in cutaneous melanoma | Q84584206 | ||
| [New putative control elements in the promoter OF CXCL13 chemokine gene, a target of alternative NF-kappaB pathway] | Q84640861 | ||
| Expression of haematogenous and lymphogenous chemokine receptors and their ligands on uveal melanoma in association with liver metastasis | Q85483334 | ||
| CC chemokine ligand 21 enhances the immunogenicity of the breast cancer cell line MCF-7 upon assistance of TLR2. | Q39621093 | ||
| Activated local immunity by CC chemokine ligand 19-transduced embryonic endothelial progenitor cells suppresses metastasis of murine ovarian cancer | Q39775202 | ||
| Tertiary intratumor lymphoid tissue in colo-rectal cancer | Q39799097 | ||
| A novel function of CXCL13 to stimulate RANK ligand expression in oral squamous cell carcinoma cells | Q39813895 | ||
| IRF-5 is a mediator of the death receptor-induced apoptotic signaling pathway | Q39912926 | ||
| Lymphoid neogenesis and immune infiltration in aged liver | Q40184795 | ||
| Hepatic expression of the tumor necrosis factor family member lymphotoxin-beta is regulated by interleukin (IL)-6 and IL-1beta: transcriptional control mechanisms in oval cells and hepatoma cell lines | Q40418664 | ||
| B cell response to tumor antigens is associated with depletion of B progenitors in murine colocarcinoma | Q40587409 | ||
| 12-Chemokine gene signature identifies lymph node-like structures in melanoma: potential for patient selection for immunotherapy? | Q41883987 | ||
| CCL19 reduces tumour burden in a model of advanced lung cancer | Q41911701 | ||
| The prognostic significance of B lymphocytes in invasive carcinoma of the breast. | Q42489904 | ||
| High expression of lymphocyte-associated genes in node-negative HER2+ breast cancers correlates with lower recurrence rates | Q42521534 | ||
| Signaling through IFN regulatory factor-5 sensitizes p53-deficient tumors to DNA damage-induced apoptosis and cell death | Q43731716 | ||
| Neogenesis of lymphoid structures and antibody responses occur in human melanoma metastases. | Q43785551 | ||
| IRF5 gene polymorphisms in melanoma | Q36380375 | ||
| MicroRNA let-7a suppresses breast cancer cell migration and invasion through downregulation of C-C chemokine receptor type 7. | Q36393145 | ||
| Lymphoid neogenesis in chronic inflammatory diseases. | Q36405080 | ||
| Prospective molecular profiling of melanoma metastases suggests classifiers of immune responsiveness. | Q36456711 | ||
| Expression of CCL19 from oncolytic vaccinia enhances immunotherapeutic potential while maintaining oncolytic activity | Q36520695 | ||
| Regulation of T(H)2 development by CXCR5+ dendritic cells and lymphotoxin-expressing B cells | Q36543544 | ||
| Keystones in lymph node development | Q36633456 | ||
| Normal structure, function, and histology of lymph nodes | Q36635903 | ||
| A new 12-gene diagnostic biomarker signature of melanoma revealed by integrated microarray analysis. | Q36773305 | ||
| Chemokine CXCL13 is overexpressed in the tumour tissue and in the peripheral blood of breast cancer patients | Q36882649 | ||
| Lung tumor NF-κB signaling promotes T cell-mediated immune surveillance | Q36891038 | ||
| CD4⁺ follicular helper T cell infiltration predicts breast cancer survival | Q36966923 | ||
| B cells are required for optimal CD4+ and CD8+ T cell tumor immunity: therapeutic B cell depletion enhances B16 melanoma growth in mice | Q37069120 | ||
| Ectopic lymphoid tissues and local immunity | Q37075235 | ||
| Humoral immunity directed against tumor-associated antigens as potential biomarkers for the early diagnosis of cancer | Q37098938 | ||
| Assessment of the immune capacity of mammary epithelial cells: comparison with mammary tissue after challenge with Escherichia coli | Q37224338 | ||
| A systematic review of humoral immune responses against tumor antigens | Q37435862 | ||
| The NF-kappaB family of transcription factors and its regulation | Q37672294 | ||
| Tumor necrosis factor, lymphotoxin and cancer | Q37692372 | ||
| CD20+ B cells: the other tumor-infiltrating lymphocytes | Q37801779 | ||
| RANKL and RANK in sex hormone-induced breast cancer and breast cancer metastasis | Q37862447 | ||
| Assessment of the humoral immune response to cancer. | Q37980913 | ||
| Tertiary lymphoid organs in infection and autoimmunity | Q38012568 | ||
| The adaptive immune response to colorectal cancer: from the laboratory to clinical practice. | Q38020591 | ||
| Immunotherapy strategies in the treatment of breast cancer | Q38072812 | ||
| Transcriptional regulation of follicular T-helper (Tfh) cells | Q38081173 | ||
| Targeting RANKL in breast cancer: bone metastasis and beyond | Q38081245 | ||
| The complexity of NF-κB signaling in inflammation and cancer | Q38126565 | ||
| Novel single-stranded oligonucleotides that inhibit signal transducer and activator of transcription 3 induce apoptosis in vitro and in vivo in prostate cancer cell lines | Q38335399 | ||
| The lymphotoxin-beta receptor is an upstream activator of NF-kappaB-mediated transcription in melanoma cells | Q38631619 | ||
| C-C chemokine receptor-7 mediated endocytosis of antibody cargoes into intact cells | Q39091628 | ||
| CCL19/CCR7 upregulates heparanase via specificity protein-1 (Sp1) to promote invasion of cell in lung cancer | Q39155424 | ||
| CCL19 as an adjuvant for intradermal gene gun immunization in a Her2/neu mouse tumor model: improved vaccine efficacy and a role for B cells as APC. | Q39253157 | ||
| Protective role of interferon regulatory factor 3-mediated signaling against prion infection. | Q39387817 | ||
| CXCL13/CXCR5 signaling enhances BCR-triggered B-cell activation by shaping cell dynamics | Q39527436 | ||
| Gene expression profiling for molecular distinction and characterization of laser captured primary lung cancers | Q30851418 | ||
| The tumor-infiltrating B cell response in medullary breast cancer is oligoclonal and directed against the autoantigen actin exposed on the surface of apoptotic cancer cells. | Q31018962 | ||
| The clinical significance of tumor infiltrating lymphoctyes in breast cancer: does subtype matter? | Q31053828 | ||
| Prognostic impact of FoxP3+ regulatory T cells in relation to CD8+ T lymphocyte density in human colon carcinomas | Q31081979 | ||
| Antigen-driven oligoclonal expansion of tumor-infiltrating B cells in infiltrating ductal carcinoma of the breast | Q31102204 | ||
| Tumor-infiltrating B lymphocytes as an efficient source of highly specific immunoglobulins recognizing tumor cells. | Q33303060 | ||
| Lymphotoxin-alpha polymorphisms and presence of cancer in 1,536 consecutive autopsy cases | Q33359870 | ||
| The chemokine CXCL13 is a key regulator of B cell recruitment to the cerebrospinal fluid in acute Lyme neuroborreliosis. | Q33611768 | ||
| Cryptic epitopes induce high-titer humoral immune response in patients with cancer. | Q33641084 | ||
| STAT inhibitors for cancer therapy. | Q33644206 | ||
| Immunosuppression and cancer. | Q33735312 | ||
| Role of CXC chemokine ligand 13 in oral squamous cell carcinoma associated osteolysis in athymic mice | Q33759518 | ||
| Prognostic value of the expression of C-Chemokine Receptor 6 and 7 and their ligands in non-metastatic breast cancer | Q33915672 | ||
| Epigenetic silencing of IRF7 and/or IRF5 in lung cancer cells leads to increased sensitivity to oncolytic viruses | Q34110261 | ||
| Stimulation of IRF-7 gene expression by tumor necrosis factor alpha: requirement for NFkappa B transcription factor and gene accessibility | Q34116996 | ||
| Ex-vivo clonally expanded B lymphocytes infiltrating colorectal carcinoma are of mature immunophenotype and produce functional IgG. | Q34185964 | ||
| Peripheral immune cell gene expression predicts survival of patients with non-small cell lung cancer | Q34222535 | ||
| The proteoglycan biglycan regulates expression of the B cell chemoattractant CXCL13 and aggravates murine lupus nephritis | Q34360138 | ||
| Interruption of CXCL13-CXCR5 axis increases upper genital tract pathology and activation of NKT cells following chlamydial genital infection | Q34493665 | ||
| Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion | Q34615273 | ||
| Gene expression analysis of peripheral blood cells reveals Toll-like receptor pathway deregulation in colorectal cancer | Q34708456 | ||
| Lymphocytic host response to oral squamous cell carcinoma: an adaptive T-cell response at the tumor interface | Q34993503 | ||
| Unique ectopic lymph node-like structures present in human primary colorectal carcinoma are identified by immune gene array profiling | Q35070183 | ||
| Four genetic polymorphisms of lymphotoxin-alpha gene and cancer risk: a systematic review and meta-analysis | Q35070335 | ||
| A critical role for dendritic cells in the formation of lymphatic vessels within tertiary lymphoid structures | Q35108664 | ||
| Naturally occurring B-cell responses to breast cancer | Q35200581 | ||
| Immune microenvironments in solid tumors: new targets for therapy | Q35642044 | ||
| CCL7 and CCL21 overexpression in gastric cancer is associated with lymph node metastasis and poor prognosis | Q35845411 | ||
| Loss of interferon regulatory factor 5 (IRF5) expression in human ductal carcinoma correlates with disease stage and contributes to metastasis | Q35889581 | ||
| Defining the critical hurdles in cancer immunotherapy | Q35916968 | ||
| Epithelial-mesenchymal transition induced by TNF-α requires NF-κB-mediated transcriptional upregulation of Twist1 | Q35952706 | ||
| CXCL13 activation of c-Myc induces RANK ligand expression in stromal/preosteoblast cells in the oral squamous cell carcinoma tumor-bone microenvironment | Q35968894 | ||
| Deep Sequence Analysis of Non-Small Cell Lung Cancer: Integrated Analysis of Gene Expression, Alternative Splicing, and Single Nucleotide Variations in Lung Adenocarcinomas with and without Oncogenic KRAS Mutations | Q35971891 | ||
| Role of the CCL21 and CCR7 pathways in rheumatoid arthritis angiogenesis | Q36131157 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 2 | |
| P921 | main subject | tertiary lymphoid structure | Q54928327 |
| P304 | page(s) | 969-997 | |
| P577 | publication date | 2014-04-23 | |
| P1433 | published in | Cancers | Q27722963 |
| P1476 | title | Role of Tertiary Lymphoid Structures (TLS) in Anti-Tumor Immunity: Potential Tumor-Induced Cytokines/Chemokines that Regulate TLS Formation in Epithelial-Derived Cancers | |
| P478 | volume | 6 |
| Q92669559 | B cells and tertiary lymphoid structures promote immunotherapy response |
| Q92978709 | B cells, plasma cells and antibody repertoires in the tumour microenvironment |
| Q44779139 | B lymphocytes and cancer: a love-hate relationship |
| Q26739445 | Biosynthesis and Functional Significance of Peripheral Node Addressin in Cancer-Associated TLO |
| Q98386390 | CD8+ T cells located in tertiary lymphoid structures are associated with improved prognosis in patients with gastric cancer |
| Q89830523 | Graph-based description of tertiary lymphoid organs at single-cell level |
| Q34290170 | HPV Infection-Associated Cancers: Next-Generation Technology for Diagnosis and Treatment |
| Q38944865 | Higher densities of Foxp3+ regulatory T cells are associated with better prognosis in triple-negative breast cancer. |
| Q41657985 | IRF5 is a novel regulator of CXCL13 expression in breast cancer that regulates CXCR5(+) B- and T-cell trafficking to tumor-conditioned media |
| Q85211594 | IRF5: a rheostat for tumor-infiltrating lymphocyte trafficking in breast cancer? |
| Q92199483 | Inhaled Submicron Particle Paclitaxel (NanoPac) Induces Tumor Regression and Immune Cell Infiltration in an Orthotopic Athymic Nude Rat Model of Non-Small Cell Lung Cancer |
| Q38255528 | On naivety of T cells in inflammatory bowel disease: a review |
| Q34733445 | Prognostic value of immune cell infiltration, tertiary lymphoid structures and PD-L1 expression in Merkel cell carcinomas. |
| Q44959093 | Tertiary Lymphoid Structures Associate with Tumour Stage in Urothelial Bladder Cancer |
| Q94948731 | Tertiary lymphoid structures in cancer - considerations for patient prognosis |
| Q38753469 | The Value of a Novel Panel of Cervical Cancer Biomarkers for Triage of HPV Positive Patients and for Detecting Disease Progression. |
| Q26799123 | Therapeutic Lymphoid Organogenesis in the Tumor Microenvironment |
Search more.